Table 1. Baseline demographic and clinical characteristics of patients .
| Bunazosin group (N = 47) | Doxazosin group (N = 46) | p value | |
| Age, years | 54.0 ± 10.8 | 55.0 ± 9.6 | 0.546 |
| Male, n (%) | 26 (55.3) | 25 (54.4) | 0.999 |
| Body weight, kg | 70.8 ± 11.2 | 66.8 ± 10.3 | 0.060 |
| Waist circumference, cm | 89.5 ± 8.5 | 87.5 ± 6.5 | 0.459 |
| Current smoker, n (%) | 4 (8.5) | 1 (2.2) | 0.361 |
| Treated hypertension | 30 (63.8) | 26 (56.5) | 0.528 |
| Systolic BP, mmHg | 143.1 ± 8.40 | 139.3 ± 11.7 | 0.211 |
| Diastolic BP, mmHg | 93.0 ± 7.0 | 91.5 ± 7.1 | 0.412 |
| Total cholesterol (mg/dl) | 206.4 ± 34.9 | 203.2 ± 45.9 | 0.403 |
| Triglycerides (mg/dl) | 138.7 ± 77.9 | 152.9 ± 97.6 | 0.634 |
| HDL-C (mg/dl) | 45.9 ± 11.8 | 43.9 ± 11.8 | 0.365 |
| LDL-C (mg/dl) | 133.5 ± 30.2 | 128.4 ± 39.3 | 0.308 |
| Fasting glucose (mg/dl) | 96.2 ± 15.9 | 100.2 ± 26.1 | 0.845 |
Values are number (%) or mean ± SD. BP, blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.